Polyethylene terephthalate microplastics induce immune evasion and malignant remodeling in breast cancer through

Ying-Chuan Yin1, Wang Zhang2, Jing He1

  • 1Department of Endocrinology, The Third People's Hospital of Hefei, Hefei Third Clinical College of Anhui Medical University, Hefei, 230022, China.

Insights

Polyethylene terephthalate (PET) microplastics (MPs) may impact breast cancer by altering immune responses and promoting tumor growth. Further research is needed to understand these immunotoxic effects on cancer development.

Area of Science:

  • Environmental Health
  • Cancer Biology
  • Immunology

Background:

  • Microplastics (MPs), particularly from polyethylene terephthalate (PET), are emerging environmental contaminants.
  • Growing concerns exist regarding their potential adverse effects on human health, especially in cancer biology.

Purpose of the Study:

  • To investigate the molecular and immunological mechanisms by which PET MPs influence breast cancer (BC) progression.
  • To identify specific immune-related genes and pathways affected by PET MPs.

Main Methods:

  • Integrative approach combining bioinformatics analysis of The Cancer Genome Atlas (TCGA) database.
  • Molecular docking simulations to assess interactions between PET oligomers and immune proteins.
  • In vitro experiments to evaluate the effects of PET MPs on cytokine secretion and cancer cell behavior.

Main Results:

  • Identified four immune-related genes (CCL19, KLRB1, CD40LG, IGLL5) potentially modulated by PET MPs.
  • Bis(2-hydroxyethyl) terephthalate (BHET), a PET oligomer, showed high-affinity binding to these immune proteins.
  • PET MPs induced pro-inflammatory cytokines (IL-6, TNF-α) and enhanced BC cell proliferation and survival.

Conclusions:

  • PET MPs may promote breast cancer progression through immune modulation and altering the tumor microenvironment (TME).
  • Findings highlight the immunotoxicity of PET MPs, necessitating further investigation into their role in cancer development.
  • Limitations include the absence of in vivo validation and immune cell co-culture models.